Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GSK163090
DRUG
2 trials
Sponsors
GlaxoSmithKline
Conditions
Depressive Disorder and Anxiety Disorders
Depressive Disorder, Major
Healthy Subjects
Major Depressive Disorder (MDD)
Phase 1
Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
Completed
NCT00435695
GlaxoSmithKline
Depressive Disorder and Anxiety Disorders, Healthy Subjects
Start: 2006-11-30
End: 2007-12-31
Updated: 2012-06-04
Patient Tolerability Study of GSK163090
Completed
NCT00559299
GlaxoSmithKline
Depressive Disorder, Major, Major Depressive Disorder (MDD)
Start: 2007-11-30
End: 2008-06-30
Target: 20
Updated: 2012-03-19